David H. Wang - Mar 1, 2024 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Signature
/s/ Mark McKechnie, Attorney-in-Fact for David H. Wang
Stock symbol
ACMR
Transactions as of
Mar 1, 2024
Transactions value $
-$8
Form type
4
Date filed
3/5/2024, 09:33 PM
Previous filing
Dec 1, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $90K +180K +35.71% $0.50* 684K Mar 1, 2024 Direct F1
transaction ACMR Class A Common Stock Tax liability -$90K -2.91K -0.43% $30.92 681K Mar 1, 2024 Direct F1
holding ACMR Class A Common Stock 100K Mar 1, 2024 By Jing Chen, wife of David H. Wang
holding ACMR Class A Common Stock 45.8K Mar 1, 2024 By Sophia Wang, daughter of David H. Wang
holding ACMR Class A Common Stock 180K Mar 1, 2024 By David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children
holding ACMR Class A Common Stock 620K Mar 1, 2024 By Wang-Chen Family Living Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -180K -21.43% $0.00 660K Mar 1, 2024 Class A Common Stock 180K $0.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2024, the reporting person exercised, by net exercise, a previously issued stock option to purchase 180,000 shares of Class A Common Stock of the Issuer. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer withholding 2,911 shares of Class A Common Stock for payment of the exercise price, based on the closing price of the Issuer's Class A Common Stock on February 29, 2024 of $30.92, and issuing to the reporting person the remaining 177,089 shares of Class A Common Stock.
F2 The option is fully vested and exercisable.

Remarks:

Chief Executive Officer, President and Director